The recent trajectory of Medvi, a telehealth company projected to achieve a staggering $1.8 billion valuation this year, casts a…
Read More
Fake testimonials, no pharmacy and an FDA warning: how Medvi built a $1.8 billion telehealth company in the gaps between regulators
The recent profile of Medvi by The New York Times earlier this month highlighted the company as a prime example…
Read More
Medvi: The $1.8 Billion Telehealth Company Built on Regulatory Gaps, Fake Testimonials, and AI Deception
A recent profile by The New York Times lauded Medvi as a prime example of artificial intelligence’s potential to empower…
Read More
